B855 (Repaglinide 2 mg)
Pill with imprint B855 is Red, Round and has been identified as Repaglinide 2 mg. It is supplied by Breckenridge Pharmaceutical, Inc..
Repaglinide is used in the treatment of diabetes, type 2 and belongs to the drug class meglitinides. Risk cannot be ruled out during pregnancy. Repaglinide 2 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for B855
Repaglinide
- Imprint:
- B855
- Strength:
- 2 mg
- Color:
- Red
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Meglitinides
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Breckenridge Pharmaceutical, Inc.
- National Drug Code (NDC):
- 51991-0855
More about repaglinide
- Repaglinide Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 9 Reviews
- Drug class: meglitinides
Consumer resources
Other brands: Prandin
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
